Medico Remedies Limited

NSE MEDICO.NS

Medico Remedies Limited EBIT Margin for the year ending March 31, 2024: 6.92%

Medico Remedies Limited EBIT Margin is 6.92% for the year ending March 31, 2024, a -10.38% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Medico Remedies Limited EBIT Margin for the year ending March 31, 2023 was 7.72%, a 28.46% change year over year.
Medico Remedies Limited EBIT Margin for the year ending March 31, 2022 was 6.01%, a 59.70% change year over year.
Medico Remedies Limited EBIT Margin for the year ending March 31, 2021 was 3.76%, a 181.20% change year over year.
Medico Remedies Limited EBIT Margin for the year ending March 31, 2020 was 1.34%, a -31.35% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

NSE: MEDICO.NS

Medico Remedies Limited

CEO	Mr. Haresh Kapurlal Mehta
IPO Date	May 26, 2022
Location	India
Headquarters	1105/1106, Hubtown Solaris
Employees	193
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.

Key trends

Past 5 years